Overview

BOTOX for the Treatment of Platysma Prominence

Status:
Completed
Trial end date:
2020-04-16
Target enrollment:
Participant gender:
Summary
To assess the efficacy and safety of BOTOX in adults with moderate to severe platysma prominence
Phase:
Phase 2
Details
Lead Sponsor:
Allergan
Treatments:
abobotulinumtoxinA
Botulinum Toxins, Type A